DRKS00026225已完成1 期
on-invasive physical plasma in the prevention and treatment of radiation dermatitis in breast cancer irradiation: a phase I-II trial - NIPP-RD
niversitätsklinikum BonnKlinik für Strahlentherapie und Radioonkologie0 个研究点目标入组 64 人开始时间: 2021年9月28日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 64
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •whole-breast irradiation (WBI)
- •- age > 18 years
- •- breast-conserving surgery for breast cancer
- •- fractionation regimen of 40.05 Gy in 15 fractions of 2.67 Gy
- •- oral and written informed consent
排除标准
- •- active smoking
- •- metastatic disease
- •- concomitant chemotherapy
- •- breast reconstruction
- •- alternative fractionation regimens
- •- history of ipsilateral breast irradiation
- •- any preexisting dermatological disorder
- •- active dermatitis
- •- current treatment with topical or oral corticosteroids
- •- patient refusal to participate
研究者
相似试验
招募中
3 期
on-Invasive Physical Plasma for Preventing Radiation Dermatitis in Breast Cancer: A Randomised Double-Blind Placebo-Controlled TrialL58.9C50.9Radiodermatitis, unspecifiedBreast, unspecifiedDRKS00032560Klinik für Strahlentherapie und Radioonkologie140
进行中（未招募）
2 期
sing blood plasma to develop passive immunity to coronavirus in EcuadorISRCTN85216856niversidad Tecnológica Equinoccial200
尚未招募
不适用
Determination of therapeutic and toxic plasma concentrations of the antipsychotic drug prothipendylsedative agent within psychotic diseasesDRKS00011452Rechtsmedizin Bonn100
招募中
不适用
Efficacy and Safety Evaluation According to Plasma Concentration Measurement on Direct Oral Anticoagulation Using Factor-Xa Inhibitors for Non-valvular Atrial Fibrillation on Multicenter Studyon-valvular atrial fibrillationJPRN-UMIN000036769Hokusetsu General Hospital Clinical laboratory division3,000
尚未招募
不适用
Itolizumab-Plasmapheresis in patients with COVID-19COVID-19SARS-CoV2Coronavirus InfectionsSARS VirusCoronaviridae InfectionsNidovirales InfectionsBetacoronavirusRPCEC00000380Center of Molecular Immunology50